Dr. Tarek M. Sabagh

Miami Valley Hospital South

Expert in Cancer
Expert in Lung Cancer
52 reported clinical trials
92 drugs studied
4 years of experience

About Tarek M. Sabagh

Education:

  • Obtained a Medical degree (MD) from the American University of Beirut Faculty of Medicine, Lebanon, in 2007.
  • Completed Residency in Internal Medicine at the University of Cincinnati Medical Center, Ohio (2008-2011).
  • Undertook a Fellowship in Gastroenterology and Hepatology at the University of Cincinnati Medical Center, Ohio (2011-2014).

Experience:

  • Currently practices as a gastroenterologist at Miami Valley Hospital South.

Area of expertise

1Cancer
Global Leader
Tarek M. Sabagh has run 21 trials for Cancer. Some of their research focus areas include:
Stage IV
metastatic
Stage III
2Lung Cancer
Global Leader
Tarek M. Sabagh has run 12 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
metastatic

Affiliated Hospitals

Image of trial facility.
Miami Valley Hospital South
Image of trial facility.
Miami Valley Hospital North

Clinical Trials Tarek M. Sabagh is currently running

Image of trial facility.

BRAF-Targeted Therapy

for Colon Cancer

This phase II/III trial compares treatment with encorafenib and cetuximab to usual care (patient observation) for reducing the chance of cancer recurrence after standard surgery and chemotherapy in patients with BRAF-mutated stage IIB-III colon cancer. Encorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cetuximab is in a class of medications called monoclonal antibodies. It binds to a protein called EGFR, which is found on some types of tumor cells. This may help keep tumor cells from growing. Giving encorafenib and cetuximab after standard surgery and chemotherapy may be more effective at reducing the chance of cancer recurrence compared to the usual patient observation.
Recruiting1 award Phase 2 & 333 criteria
Image of trial facility.

Lomustine + Standard Therapy

for Glioblastoma

This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 36 criteria

More about Tarek M. Sabagh

Clinical Trial Related4 years of experience running clinical trials · Led 52 trials as a Principal Investigator · 45 Active Clinical Trials
Treatments Tarek M. Sabagh has experience with
  • Nivolumab
  • Carboplatin
  • Cisplatin
  • Atezolizumab
  • Radiation Therapy
  • Cabozantinib S-malate

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tarek M. Sabagh specialize in?
Tarek M. Sabagh focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are metastatic.
Is Tarek M. Sabagh currently recruiting for clinical trials?
Yes, Tarek M. Sabagh is currently recruiting for 43 clinical trials in Centerville Ohio. If you're interested in participating, you should apply.
Are there any treatments that Tarek M. Sabagh has studied deeply?
Yes, Tarek M. Sabagh has studied treatments such as Nivolumab, Carboplatin, Cisplatin.
What is the best way to schedule an appointment with Tarek M. Sabagh?
Apply for one of the trials that Tarek M. Sabagh is conducting.
What is the office address of Tarek M. Sabagh?
The office of Tarek M. Sabagh is located at: Miami Valley Hospital South, Centerville, Ohio 45459 United States. This is the address for their practice at the Miami Valley Hospital South.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.